V. Ritz et al., CHARACTERIZATION OF 2 PITUITARY GH(3) CELL SUBLINES PARTIALLY RESISTANT TO APOPTOSIS INDUCTION BY OKADAIC ACID, Biochemical pharmacology, 54(9), 1997, pp. 967-971
Pituitary GH(3) cells die by apoptosis when treated with okadaic acid,
a specific inhibitor of ser/thr phosphatases. Incubations starting at
concentrations of 5 and 12.5 nM followed by stepwise rises resulted i
n two populations (the S-1 and S-2 sublines) that proliferated at init
ially lethal 30 nM. Cells were partially resistant to higher concentra
tions of okadaic acid and its derivative methyl okadaate. Toxicity of
the structurally distinct inhibitors cantharidic acid and calyculin A
was differently affected in the two resistant lines. The enhanced expr
ession of the P-glycoprotein was one mechanism of resistance in S-1 an
d S-2. Resistance was reversed completely (S-1) or partially (S-2) by
the addition of verapamil. In addition, phosphatase activity, presumab
ly PP2A, was increased in S-2. Therefore, pharmacokinetic and pharmaco
dynamic mechanisms can protect pituitary GH(3) cells from apoptotic ce
ll death by okadaic acid. (C) 1997 Elsevier Science Inc.